Viewing Study NCT00129740

Bugs

Ignite Creation Date: 2025-12-18 @ 9:16 AM

Ignite Modification Date: 2025-12-23 @ 6:12 PM

Study NCT ID: NCT00129740

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module